avatar

PROF. DR. HASNIZA BINTI ZAMAN HURI

Department of Clinical Pharmacy and Pharmacy Practice

Faculty of Pharmacy

hasnizazhum.edu.my
Statistics
Annual Publications by Category
Summary of Budget vs Expenditure per vote for all research grants
Last 3 Projects
Project Title Progress Status
Targeting Lipogenic Pathway In T2dm Patients With Cardiovascular Disease: Unravelling The Cardio-protective Mechanism Of Sglt2-inhibitor On Epicardial Fat Thickness Via Multi-omics Approach
new
"health Intervention Programme And Public Perception In The Management Of Non-communicable Diseases (ncds) In Community Pharmacy In Malaysia "
on going
Effect Of Slc22a1 Gene Polymorphisms On Glycemic Control And Metformin Intolerance In Type 2 Diabetes Patients At St Paul's Hospital And Zewuditu Memorial Hospital, Addis Ababa, Ethiopia
on going
This information is generated from Research Grant Management System
Latest Publications
2024

Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus

2024

The impact of perceived vaginal and urinary symptoms and treatment burden in predicting sexual functioning among perimenopausal and postmenopausal women

2024

Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters

2024

Personalised learning in higher education for health sciences: a scoping review protocol

2017

Utilisation of Variable Rate Intravenous Insulin Infusion

2015

Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts

2015

Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly

2012

Training Manual for Pharmacists for Management of Obesity and Overweight.

2012

Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease

2011

Dyslipidemia and type 2 diabetes mellitus: Implications and role of antiplatelet agents in primary prevention of cardiovascular diseases.